The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: A follow-up study

British Journal of Dermatology

Volumn 157, Issue 3, 2007, Pages 508-513

  Sampogna, F ^a   Tabolli, S ^a   Abeni, D ^a   Alotto, Massimo ^b   Antonelli, Gianluca ^b   Bolli, Simone ^b   Cavalieri, Rino ^b   Chinni, Massimo Luca ^b   Fazio, Marcello ^b   Girolomoni, Giampiero ^b   Luchetti, Elisabetta ^b   Mazzotti, Eva ^b   Melchi, Carmelo Franco ^b   Salcedo, Nidia Melo ^b   Moscatelli, Paola ^b   Pasquini, Paolo ^b   Piazza, Paolo ^b   Picconi, Orietta ^b   Pilla, Maria Antonietta ^b   Primavera, Grazia ^b   Puddu, Pietro ^b   Ruatti, Paolo ^b   Ruggiero, Giuseppe ^b   Salvatori, Valentina ^b   Sera, Francesco ^b   Simoni, Romeo ^b   Sordi, Donatella ^b   Tiago, Albertina ^b   more..

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b NONE

Author keywords

Psoriasis; Psychology; Quality of life; Severity

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENERAL HEALTH QUESTIONNAIRE; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MORBIDITY; PRIORITY JOURNAL; PSORIASIS;

AGED; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PSORIASIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STRESS, PSYCHOLOGICAL;

EID: 34547865733     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08071.x     Document Type: Article

References (25)

1. Anzieu D. Le Moi-peau, 2nd edn. Paris : Dunod, 1995.
2. Hughes JE, Barraclough BM, Hamblin LG et al. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983 143 : 51 4.
3. Wessely SC, Lewis GH. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989 155 : 686 91.
4. Picardi A, Abeni D, Melchi CF et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000 143 : 983 91.
5. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003 4 : 833 42.
6. Zachariae R, Zachariae C, Ibsen HH et al. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol (Stockh) 2004 84 : 205 12.
7. Fortune DG, Richards HL, Griffiths CE. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin 2005 23 : 681 94.
8. Akay A, Pekcanlar A, Bozdag KE et al. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002 16 : 347 52.
9. Devrimci-Ozguven H, Kundakci TN, Kumbasar H et al. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000 14 : 267 71.
10. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989 20 : 53 63.
11. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol 1997 36 : 259 62.
12. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998 139 : 846 50.
13. Gupta MA, Gupta AK, Kirkby S et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol 1988 124 : 1052 7.
14. Fortune DG, Richards HL, Kirby B et al. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being. Br J Dermatol 2004 151 : 1219 26.
15. Sampogna F, Sera F, Mazzotti E et al. Performance of the self-administered Psoriasis Area and Severity Index in evaluating clinical and sociodemographic subgroups of patients with psoriasis. Arch Dermatol 2003 139 : 353 8.
16. Sampogna F, Sera F, Abeni D. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004 122 : 602 7.
17. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978 157 : 238 44.
18. Feldman SR, Fleischer AB Jr., Reboussin DM et al. The self-administered Psoriasis Area and Severity Index is valid and reliable. J Invest Dermatol 1996 106 : 183 6.
19. Chren MM, Lasek RJ, Flocke SA et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997 133 : 1433 40.
20. Abeni D, Picardi A, Pasquini P et al. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2242 dermatological outpatients. Dermatology 2002 204 : 43 9.
21. Bellantuono C, Fiorio R, Zanotelli R et al. Psychiatric screening in general practice in Italy. A validity study of the GHQ (General Health Questionnaire). Soc Psychiatry 1987 22 : 113 17.
22. Goldberg D. The Detection of Psychiatric Illness by Questionnaire. London : Oxford University Press, 1972.
23. Picardi A, Abeni D, Mazzotti E et al. Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12-item General Health Questionnaire (GHQ-12). J Psychosom Res 2004 57 : 219 23.
24. Ayyalaraju RS, Finlay AY. Inpatient dermatology. United Kingdom and United States similarities: moving with the times or being relegated to the back bench? Dermatol Clin 2000 18 : 397 404, vii viii.
25. Ayyalaraju RS, Finlay AY, Dykes PJ et al. Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: a comparative study. J Am Acad Dermatol 2003 49 : 249 54.